Your browser doesn't support javascript.
loading
Efficacy and safety of anti-angiogenic drugs combined with erlotinib in the treatment of advanced non-small cell lung cancer: a meta-analysis of randomized clinical trials.
Chen, Zheng; Jiang, Shu; Li, Xuechun; Zhang, Jingyao; Liu, Liu; Li, Juan; Cao, Peiyu; Xin, Yong; Zhang, Longzhen.
Afiliação
  • Chen Z; Department of Radiotherapy, Xuzhou Medical College Affiliated Hospital, Xuzhou, China.
  • Jiang S; Department of Radiotherapy, Xuzhou Medical College Affiliated Hospital, Xuzhou, China.
  • Li X; Department of Radiotherapy, Xuzhou Medical College Affiliated Hospital, Xuzhou, China.
  • Zhang J; Department of Radiotherapy, Xuzhou Medical College Affiliated Hospital, Xuzhou, China.
  • Liu L; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
  • Li J; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
  • Cao P; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
  • Xin Y; Department of Radiotherapy, Xuzhou Medical College Affiliated Hospital, Xuzhou, China. deep369@163.com.
  • Zhang L; Department of Radiotherapy, Xuzhou Medical College Affiliated Hospital, Xuzhou, China. jsxzzlz@126.com.
Ann Palliat Med ; 10(3): 2687-2698, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33548993

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: Ann Palliat Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: Ann Palliat Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: China